DOI
10.1200/JCO.22.02345
CAR T-Cells for Cure in Pediatric B-ALL
Authors
Rebecca A. Gardner
Division of Hematology and Oncology University of Washington, Seattle Children's Hospital, Seattle, WA
Rebecca A. Gardner, Nirali N. Shah
Preview
Journal Details
Published Date
January 12, 2023
Similar Journals
Journal
Journal of Clinical Oncology
CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial
First Author: Nirali N. Shah
Publish Date: Apr 1, 2020
Journal
Journal of Clinical Oncology
Coadministration of CD19- and CD22-Directed Chimeric Antigen Receptor T-Cell Therapy in Childhood B-Cell Acute Lymphoblastic Leukemia: A Single-Arm, Multicenter, Phase II Trial
First Author: Tianyi Wang
Publish Date: Nov 8, 2022
Journal
Journal of Clinical Oncology
Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
First Author: Claire Roddie
Publish Date: Aug 1, 2021
Journal
Journal of Clinical Oncology
Chimeric Antigen Receptor T-Cell Therapy in the Management of Relapsed Non-Hodgkin Lymphoma
First Author: Krishna V. Komanduri
Publish Date: Jan 12, 2021